Presentation is loading. Please wait.

Presentation is loading. Please wait.

European Urology Oncology

Published byGabriele Cipriani Modified over 5 years ago

Similar presentations

Presentation on theme: "European Urology Oncology"— Presentation transcript:

1 European Urology Oncology
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer  Alberto Martini, Giorgio Gandaglia, Nicola Fossati, Simone Scuderi, Carlo Andrea Bravi, Elio Mazzone, Armando Stabile, Simone Scarcella, Daniele Robesti, Francesco Barletta, Vito Cucchiara, Vincenzo Mirone, Francesco Montorsi, Alberto Briganti  European Urology Oncology  DOI: /j.euo Copyright © 2019 European Association of Urology Terms and Conditions

2 Fig. 1 Kaplan-Meier curve depicting biochemical recurrence-free survival and clinical recurrence-free survival in the overall patient population. BCR=biochemical recurrence; CR=clinical recurrence. European Urology Oncology DOI: ( /j.euo ) Copyright © 2019 European Association of Urology Terms and Conditions

3 Fig. 2 Kaplan-Meier curve depicting biochemical recurrence-free survival, stratified according to margins features. BCR=biochemical recurrence; PSM=positive surgical margin. European Urology Oncology DOI: ( /j.euo ) Copyright © 2019 European Association of Urology Terms and Conditions

4 Fig. 3 Kaplan-Meier curve depicting clinical recurrence-free survival, stratified according to margins features. CR=clinical recurrence; PSM=positive surgical margin. European Urology Oncology DOI: ( /j.euo ) Copyright © 2019 European Association of Urology Terms and Conditions

5 Fig. 4 Kaplan-Meier curve depicting biochemical recurrence-free survival, stratified according to margins features in patients with adverse pathologic features. BCR=biochemical recurrence; PSM=positive surgical margin. European Urology Oncology DOI: ( /j.euo ) Copyright © 2019 European Association of Urology Terms and Conditions

6 Fig. 5 Kaplan-Meier curve depicting clinical recurrence-free survival, stratified according to margins features in patients with adverse pathologic features. CR=clinical recurrence; PSM=positive surgical margin. European Urology Oncology DOI: ( /j.euo ) Copyright © 2019 European Association of Urology Terms and Conditions

Download ppt "European Urology Oncology"

Similar presentations

Volume 72, Issue 3, Pages (September 2017)

Volume 72, Issue 3, Pages (September 2017)
An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer  Marco Bandini, Giorgio Gandaglia, Nicola Fossati, Francesco.

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer  Marco Bandini, Giorgio Gandaglia, Nicola Fossati, Francesco.
Volume 68, Issue 6, Pages (December 2015)

Volume 68, Issue 6, Pages (December 2015)
Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction? 

Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction? 
Volume 62, Issue 3, Pages (September 2012)

Volume 62, Issue 3, Pages (September 2012)
Volume 155, Issue 3, Pages (March 1996)

Volume 155, Issue 3, Pages (March 1996)
The PSA Era is not Over for Prostate Cancer

The PSA Era is not Over for Prostate Cancer
Oncological outcomes of high risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy.

Oncological outcomes of high risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy.
Oncol Res Treat 2016;39: DOI: /

Oncol Res Treat 2016;39: DOI: /
The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.
Volume 58, Issue 4, Pages (October 2010)

Volume 58, Issue 4, Pages (October 2010)
Testosterone Therapy in Men With Prostate Cancer

Testosterone Therapy in Men With Prostate Cancer
Volume 58, Issue 5, Pages (November 2010)

Volume 58, Issue 5, Pages (November 2010)
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer  Francesco Cantiello, Giorgio.

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer  Francesco Cantiello, Giorgio.
European Urology Oncology

European Urology Oncology
Volume 59, Issue 5, Pages (May 2011)

Volume 59, Issue 5, Pages (May 2011)
Volume 68, Issue 3, Pages (September 2015)

Volume 68, Issue 3, Pages (September 2015)
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database 

Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database 
Volume 69, Issue 1, Pages (January 2016)

Volume 69, Issue 1, Pages (January 2016)

Similar presentations

Ads by Google